SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas redesigned Roadster reveal featuring SpaceX-developed thrusters is driving attention, with bullish traders praising the engineering and speculating about closer TeslaSpaceX ties, while skeptics question the cars practicality, regulatory prospects, and business impact.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Rapid sellouts and delivery delays for preorders of Apples foldable iPhone Duo are driving attention, with bulls reading them as strong demand and skeptics arguing limited initial supply may explain the wait times. Traders are also debating Apples resilience as money rotates away from pressured AI and chip stocks, while questioning whether the new device can support its rich valuation.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is caught in a broader neocloud selloff as concerns about debt-funded AI data-center expansion and rising financing costs weigh on the sector; Morningstar also lowered its outlook for IREN. Traders are divided between fears of further losses and dilution and dip-buying on the view that IRENs balance sheet and customer funding leave it better positioned than some peers.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Goldman Sachs upgrade to Buy, alongside broader analyst optimism about Zetas AI-driven marketing platform and enterprise growth, is fueling attention as shares reach new highs. Bulls are celebrating the breakout and adding, while some traders caution that the run may be extended and expect profit-taking or consolidation.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs workforce cuts and replacement of its content chief with Peter Rice are stirring debate ahead of earnings, amid concerns about viewer engagement, content quality, and slowing growth. Some traders view the changes as a path to tighter costs and a content reset, while others see them as signs of business weakness; bullish and bearish views also differ on the stocks recent rebound.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows AI Passport launch, NVIDIA partnership, and EmployeeWorks AI-agent upgrades are drawing attention as investors weigh its enterprise AI opportunity. Traders are also celebrating the sharp move through prior resistance and watching for a sustained breakout, while some caution that the rally may stall near resistance ahead of earnings.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

European regulators upheld the negative opinion on Omeros narsoplimab application after re-examination, limiting the prospect of broad European access to Yartemlea. Traders are debating Omeros claim that patient-level data were not shared with expert reviewers; some see the decision as a setback, while others point to U.S. sales and possible named-patient access in Europe as offsets.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Concerns about CoreWeaves debt burden and falling bond prices have fueled sharp swings, with traders debating whether financing risks threaten its AI infrastructure expansion or are overstated given demand and contracted business. Nvidia CEO Jensen Huangs supportive comments helped lift sentiment, prompting dip-buying, while skeptics argue the reassurance does not resolve the underlying credit concerns.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

A sharp memory-sector selloff and weakness in South Korean shares are driving attention, with traders debating whether the AI memory boom is normalizing amid Chinese competition and questions about AI investment returns. Bears expect further pressure, while bulls argue the competitive threat is still distant and view the drop as an overreaction.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Teslas Roadster reveal, featuring SpaceX thruster technology, has fueled speculation about a TeslaSpaceX merger and renewed attention to SpaceXs engineering ambitions. Traders are divided between viewing the demo as a sign of future potential and dismissing it as a promotional stunt, while also debating the stocks valuation and share-unlock pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cancer Stocks That Are Advancing the Future of Oncology Care

Oncology innovation is accelerating as AI, immunotherapy and targeted drugs drive growth for cancer-focused biotech and pharma stocks.

Xilio Therapeutics, Inc. (XLO) Reports Q1 Loss, Beats Revenue Estimates

Xilio Therapeutics (XLO) delivered earnings and revenue surprises of +12.12% and +48.45%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Opus Genetics, Inc. (IRD) Reports Q1 Loss, Misses Revenue Estimates

Opus Genetics, Inc. (IRD) delivered earnings and revenue surprises of -374.68% and -23.18%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Oculis Holding AG (OCS) Reports Q1 Loss, Lags Revenue Estimates

Oculis Holding AG (OCS) delivered earnings and revenue surprises of -27.71% and -17.08%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Xilio Therapeutics (XLO) Upgraded to Buy: What Does It Mean for the Stock?

Xilio Therapeutics (XLO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Wall Street Zen Upgrades Xilio Therapeutics (NASDAQ:XLO) to Buy

Wall Street Zen raised Xilio Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...

Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market

Oncology is evolving fast as immunotherapy, AI and targeted drugs expand treatment options, boost outcomes, and fuel long-term healthcare growth.

Xilio Therapeutics (NASDAQ:XLO) Shares Down 4.8% - What's Next?

Xilio Therapeutics (NASDAQ:XLO) Stock Price Down 4.8% - What's Next...

Xilio Therapeutics (NASDAQ:XLO) Sees Unusually-High Trading Volume - Here's What Happened

Xilio Therapeutics (NASDAQ:XLO) Sees Strong Trading Volume - Here's Why...

Xilio Therapeutics, Inc. (XLO) Reports Q3 Loss, Misses Revenue Estimates

Xilio Therapeutics (XLO) delivered earnings and revenue surprises of 0.00% and -28.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of tumor-activated immuno-oncology therapies for the treatment of cancer. The firm uses its Geographically Precise Solutions (GPS) platform to develop tumor-activated molecules, including cytokines, antibodies and other biologics. The company was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.

Xilio Therapeutics Inc

Xilio Stock Jumps 8% On Cancer Drug Data; Gilead Boost Extends Cash Runway Into 2027 — Retail Says Stock Undervalued

Equity

Bearish Sentiment

50bps hike

25bps hike

No change

Rate cut

September CPI rose 0.6% from the prior month to 3.7% annually, while producer prices jumped 6.3% year-over-year, the biggest gain since 2022, putting the Federal Reserve's October 27-28 meeting squarely in focus after its first rate hike in three years last month. What does the Fed do at its October meeting? Vote and explain your reasoning in the comments.

September CPI hit 3.7% and PPI jumped 6.3%, both hotter than expected. What does the Fed do at its October meeting?

Stocktwits

Stocktwits Polls

$XLO Nice hire! Yariv's experience taking a cancer drug from early trials through approval makes this a meaningful hire. Choosing to join Xilio at this stage is encouraging, and the Gilead connection adds intrigue. There’s reason to be excited about it.

$XLO November is almost here.
This is where the new reduce strike  price applies to employees and management. Probably the reason they are holding the stock at $9 and why they didn’t PR any of the milestone paid by AbbVie.

809 Trader

$XLO if Gilead decides to take over XTX301 development, maybe they'll say " what the hell, let's grab the the whole outfit"....wouldn't that be nice......Yariv definitely a plus I think

kyle matthews

$XLO ask yourself why aren’t  the big institution that owns this puppy  buying the stock. Their average is way higher. $10 million dollars will send this puppy to $50. They are not buying because they have inside information. They know about the deal.

$XLO 800 shares traded today all day. 🫪😂🥳 just tell us who the new owner is and give us our money. Thanks!!!

Feed

News

Sentiment

Fundamentals

Info

XLO Xilio Therapeutics Inc

Fundamentals

Latest XLO News